FREE U.S. SHIPPING + NO HIDDEN FEES

Ivermectin Study Published in Anticancer Research Journal : Read Here

Save Up To 50% Off Select Products

News & Insights

How Does Body Weight Affect Cancer Risk and Treatment?

How Does Body Weight Affect Cancer Risk and Treatment?

Cancer Care · Metabolic Health


The link between body weight and cancer is one of the most well-established — and most underappreciated — relationships in oncology. It’s not about appearance. It’s about biology. Excess body fat drives hormonal and metabolic changes that create conditions where cancer can develop, grow, and resist treatment.

The Numbers Are Striking

The American Cancer Society estimates that excess body weight is a contributing factor in approximately 11% of cancers in women and 5% in men in the United States. (1) Obesity is associated with increased risk of at least 13 types of cancer, including colorectal, breast (post-menopausal), endometrial, kidney, pancreatic, esophageal, and liver cancers. (2)

Why the Biology Works This Way

Insulin and IGF-1. Obesity drives insulin resistance. High insulin and IGF-1 promote cell proliferation and inhibit programmed cell death — two processes fundamental to cancer development. (3)

Chronic inflammation. Visceral fat produces pro-inflammatory cytokines including TNF-alpha and interleukin-6, creating a cellular environment that favors tumor growth. (4)

Sex hormones. Adipose tissue converts androgens to estrogens. In post-menopausal women, excess body fat becomes a major source of estrogen — directly driving hormone-receptor-positive breast and endometrial cancers. (5)

Cancers Most Strongly Associated With Excess Body Weight

  • Colorectal cancer
  • Breast cancer (post-menopausal)
  • Endometrial cancer
  • Kidney and renal pelvis cancer
  • Pancreatic cancer
  • Esophageal adenocarcinoma
  • Liver cancer

How Weight Affects Treatment Outcomes

Obesity complicates chemotherapy dosing — drug distribution changes with body composition, and underdosing to avoid toxicity can compromise effectiveness. Surgical complications are more frequent in patients with excess weight. And elevated insulin and inflammatory markers can blunt the immune response that helps the body fight residual cancer. (6)

On the other side, unintended weight loss during treatment — particularly muscle loss from cancer cachexia — is equally serious. The goal isn’t thinness. It’s metabolic health: stable blood sugar, controlled inflammation, and preserved lean muscle mass.

What You Can Actually Do About It

For people currently in treatment, the priority is maintaining weight and muscle — not losing weight. For people post-treatment or in prevention, even modest reductions of 5 to 10 percent of body weight meaningfully reduce insulin levels, inflammatory markers, and circulating estrogens. (7) Stabilizing blood sugar is one of the most impactful levers available.

The Bottom Line

Excess body weight is one of the most significant and modifiable cancer risk factors. During treatment, focus on metabolic stability, not weight loss. After treatment, even modest improvements in metabolic health can meaningfully reduce recurrence risk.

Peak Metabolism supplement

Supplements / Metabolic Health

Peak Metabolism — Mother Nature’s Metabolism Support

Formulated with Berberine, Banaba Leaf, Chromium, and Bitter Melon to support balanced blood sugar, reduce glucose spikes, and promote healthy metabolic function. Non-GMO, vegan, and allergen-free.

Shop Now

References

  1. American Cancer Society. (2020). Diet and Physical Activity: What’s the Cancer Connection?
  2. Lauby-Secretan, B., et al. (2016). Body fatness and cancer. NEJM, 375(8), 794–798.
  3. Gallagher, E. J., & LeRoith, D. (2015). Obesity and diabetes: The increased risk for cancer. Physiological Reviews, 95(3), 727–748.
  4. Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420(6917), 860–867.
  5. Key, T. J., et al. (2003). Body mass index, serum sex hormones, and breast cancer risk. JNCI, 95(16), 1218–1226.
  6. Griggs, J. J., et al. (2012). Appropriate chemotherapy dosing for obese adult patients with cancer. JCO, 30(13), 1553–1561.
  7. Rock, C. L., et al. (2020). ACS guideline for diet and physical activity for cancer prevention. CA: Cancer J Clin, 70(4), 245–271.

Author

Derek Simon

This article is for informational purposes only and does not constitute medical advice. Always consult your oncologist or a qualified healthcare provider before making changes to your diet, exercise, or supplement regimen.


About our editorial team

The TWC Editorial team is comprised of various wellness practitioners from physiotherapists, acupuncturists, fitness instructors, herbalists, and MDs.

This article does not constitute medical advice. Please consult a healthcare provider for proper diagnosis and treatment.
Terms of Service

YOUR CART (0)

No Items in the Cart